Nifty
Sensex
:
:
11987.65
40648.47
-11.45 (-0.10%)
-3.17 (-0.01%)

Hospital & Healthcare Services

Rating :
73/99  (View)

BSE: 508869 | NSE: APOLLOHOSP

1452.55
31.00 (2.18%)
21-Nov-2019 | 12:04PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  1428.00
  •  1457.00
  •  1425.00
  •  1421.55
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  556963
  •  8090.17
  •  1579.70
  •  1083.10

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 19,777.34
  • 59.30
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 23,101.65
  • 0.42%
  • 5.33

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 30.80%
  • 0.48%
  • 4.80%
  • FII
  • DII
  • Others
  • 5.71%
  • 8.39%
  • 49.82%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 16.40
  • 12.66
  • 9.78

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.73
  • 8.47
  • 6.24

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.14
  • -2.67
  • 2.02

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 51.43
  • 56.17
  • 61.16

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 4.64
  • 4.92
  • 4.49

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 22.61
  • 23.55
  • 21.67

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Sep 19
Sep 18
Var%
Jun 19
Jun 18
Var%
Mar 19
Mar 18
Var%
Dec 18
Dec 17
Var%
Net Sales
2,840.74
0.00
0.00
2,571.89
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Expenses
2,427.26
0.00
0.00
2,208.17
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBITDA
413.48
0.00
0.00
363.72
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBIDTM
14.56%
0.00%
14.14%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
3.50
0.00
0.00
9.86
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Interest
134.34
0.00
0.00
125.77
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
154.51
0.00
0.00
144.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PBT
128.13
0.00
0.00
103.80
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax
50.55
0.00
0.00
45.25
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT
77.58
0.00
0.00
58.55
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PATM
2.73%
0.00%
2.28%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
6.20
0.00
0.00
4.11
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Net Sales
-
9,617.44
8,243.47
7,255.70
6,214.65
5,178.45
4,384.22
3,768.71
3,147.53
2,605.35
2,026.46
Net Sales Growth
-
16.67%
13.61%
16.75%
20.01%
18.12%
16.33%
19.74%
20.81%
28.57%
 
Cost Of Goods Sold
-
4,660.87
4,032.66
3,598.88
3,054.74
2,581.20
2,150.13
1,855.83
1,562.33
1,314.86
979.06
Gross Profit
-
4,956.57
4,210.81
3,656.83
3,159.91
2,597.26
2,234.09
1,912.87
1,585.20
1,290.49
1,047.41
GP Margin
-
51.54%
51.08%
50.40%
50.85%
50.16%
50.96%
50.76%
50.36%
49.53%
51.69%
Total Expenditure
-
8,553.78
7,450.29
6,548.95
5,534.38
4,443.78
3,711.81
3,160.51
2,634.41
2,186.49
1,725.90
Power & Fuel Cost
-
183.83
166.68
127.89
122.80
93.98
85.33
69.93
54.87
47.39
38.26
% Of Sales
-
1.91%
2.02%
1.76%
1.98%
1.81%
1.95%
1.86%
1.74%
1.82%
1.89%
Employee Cost
-
1,598.24
1,404.39
1,196.50
1,023.55
860.02
727.45
623.13
502.86
415.12
310.65
% Of Sales
-
16.62%
17.04%
16.49%
16.47%
16.61%
16.59%
16.53%
15.98%
15.93%
15.33%
Manufacturing Exp.
-
511.99
453.39
430.28
393.04
246.61
200.01
157.83
136.68
112.21
134.72
% Of Sales
-
5.32%
5.50%
5.93%
6.32%
4.76%
4.56%
4.19%
4.34%
4.31%
6.65%
General & Admin Exp.
-
1,461.23
1,271.85
1,100.53
862.57
612.33
516.37
423.11
350.29
277.89
241.96
% Of Sales
-
15.19%
15.43%
15.17%
13.88%
11.82%
11.78%
11.23%
11.13%
10.67%
11.94%
Selling & Distn. Exp.
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
% Of Sales
-
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Miscellaneous Exp.
-
137.63
121.32
94.88
77.67
49.63
32.52
30.67
27.38
19.02
0.00
% Of Sales
-
1.43%
1.47%
1.31%
1.25%
0.96%
0.74%
0.81%
0.87%
0.73%
1.05%
EBITDA
-
1,063.66
793.18
706.75
680.27
734.67
672.41
608.20
513.12
418.86
300.56
EBITDA Margin
-
11.06%
9.62%
9.74%
10.95%
14.19%
15.34%
16.14%
16.30%
16.08%
14.83%
Other Income
-
31.44
32.15
44.33
52.54
36.75
21.46
30.17
25.91
15.05
32.24
Interest
-
327.02
295.07
257.35
180.02
117.85
119.38
103.25
89.14
77.85
60.21
Depreciation
-
395.52
359.03
314.04
263.83
211.65
167.79
142.34
123.91
94.75
74.95
PBT
-
372.56
171.24
179.69
288.95
441.92
406.71
392.78
325.97
261.32
197.64
Tax
-
173.37
111.91
90.96
96.90
130.00
101.76
105.04
114.96
87.30
67.61
Tax Rate
-
46.53%
65.35%
50.62%
31.78%
28.55%
25.02%
26.32%
35.27%
33.41%
34.21%
PAT
-
235.07
117.19
178.60
209.14
330.55
306.31
295.70
212.24
175.54
133.66
PAT before Minority Interest
-
199.19
59.33
88.73
207.99
325.41
304.94
294.04
211.01
174.02
130.03
Minority Interest
-
35.88
57.86
89.87
1.15
5.14
1.37
1.66
1.23
1.52
3.63
PAT Margin
-
2.44%
1.42%
2.46%
3.37%
6.38%
6.99%
7.85%
6.74%
6.74%
6.60%
PAT Growth
-
100.59%
-34.38%
-14.60%
-36.73%
7.91%
3.59%
39.32%
20.91%
31.33%
 
Unadjusted EPS
-
16.97
8.44
15.88
16.99
24.43
22.77
21.62
16.83
14.84
22.29

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Shareholder's Funds
3,333.47
3,251.51
3,313.20
3,331.13
3,171.33
2,976.68
2,746.77
2,506.82
1,898.94
1,653.48
Share Capital
69.56
69.56
73.01
69.56
69.56
69.56
69.56
67.23
62.35
61.78
Total Reserves
3,261.10
3,180.05
3,238.91
3,260.64
3,100.63
2,907.12
2,677.21
2,400.88
1,768.08
1,591.69
Non-Current Liabilities
4,612.96
4,423.17
4,398.65
2,700.91
2,138.49
1,557.42
1,315.77
736.78
1,045.99
966.80
Secured Loans
2,868.71
2,728.43
2,477.64
2,303.08
1,563.22
1,050.25
1,057.48
514.29
650.49
676.47
Unsecured Loans
83.42
195.37
475.74
146.70
164.83
172.13
21.41
60.08
97.51
236.73
Long Term Provisions
883.02
784.96
701.39
3.27
3.45
2.20
2.79
2.17
208.06
0.00
Current Liabilities
1,955.38
1,567.23
963.36
1,249.83
1,076.33
796.77
734.03
726.44
632.56
597.34
Trade Payables
713.12
606.02
501.19
550.19
419.14
280.37
221.76
190.33
192.25
226.97
Other Current Liabilities
640.84
501.70
295.59
446.16
439.91
320.99
336.90
282.93
228.20
108.80
Short Term Borrowings
498.16
379.17
70.69
182.93
85.74
62.50
57.88
174.99
142.73
0.00
Short Term Provisions
103.25
80.33
95.89
70.55
131.54
132.92
117.49
78.19
69.38
261.56
Total Liabilities
10,037.27
9,374.35
8,799.79
7,359.80
6,459.16
5,349.65
4,813.91
3,982.60
3,602.37
3,241.76
Net Block
4,975.06
4,765.71
4,583.29
3,997.42
3,244.12
2,681.29
2,340.59
2,011.25
1,529.51
1,321.96
Gross Block
6,599.08
6,023.63
5,499.02
4,609.14
4,285.44
3,570.60
3,096.80
2,640.88
2,047.83
1,745.02
Accumulated Depreciation
1,624.02
1,257.92
915.73
611.73
1,041.32
889.31
756.22
625.76
514.46
423.06
Non Current Assets
7,755.53
7,154.22
6,670.57
5,385.23
4,520.29
3,848.77
3,260.51
2,920.16
2,723.60
2,042.18
Capital Work in Progress
821.77
712.20
346.86
561.56
532.64
491.31
403.39
209.27
361.00
303.71
Non Current Investment
399.35
301.26
307.96
270.65
165.08
166.07
147.95
442.17
386.14
416.51
Long Term Loans & Adv.
1,431.65
1,254.62
1,325.53
498.28
578.45
510.11
368.57
248.89
443.86
0.00
Other Non Current Assets
127.70
120.43
106.93
57.33
0.00
0.00
0.00
8.57
3.09
0.00
Current Assets
2,281.73
2,220.13
2,129.22
1,974.57
1,938.88
1,500.89
1,553.41
1,062.44
878.77
1,199.57
Current Investments
68.83
57.87
105.84
81.73
145.57
155.50
378.76
121.98
115.86
0.07
Inventories
584.78
565.84
466.87
406.13
350.26
278.55
218.68
191.54
158.44
141.22
Sundry Debtors
1,023.20
825.19
750.53
609.37
609.27
519.77
473.30
386.73
300.31
222.84
Cash & Bank
346.96
417.25
524.50
378.79
377.33
274.15
320.06
236.84
178.12
311.67
Other Current Assets
257.97
241.68
58.44
61.30
456.43
272.93
162.60
125.35
126.04
523.76
Short Term Loans & Adv.
87.57
112.29
223.03
437.25
419.99
240.72
138.97
98.44
98.84
511.55
Net Current Assets
326.36
652.90
1,165.86
724.74
862.55
704.12
819.37
336.00
246.21
602.23
Total Assets
10,037.26
9,374.35
8,799.79
7,359.80
6,459.17
5,349.66
4,813.92
3,982.60
3,602.37
3,241.76

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Cash From Operating Activity
904.95
536.96
622.55
597.17
469.95
373.39
442.75
387.05
258.83
198.63
PBT
200.17
59.56
131.12
305.25
455.41
406.71
399.08
325.97
261.32
197.64
Adjustment
943.01
807.85
703.53
425.00
274.83
289.98
226.59
210.32
168.93
116.70
Changes in Working Capital
-45.79
-205.35
-78.48
10.82
-160.83
-214.04
-90.08
-87.29
-104.22
-29.42
Cash after chg. in Working capital
1,097.38
662.06
756.17
741.07
569.42
482.64
535.58
449.00
326.03
284.93
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-192.43
-125.10
-133.62
-141.19
-100.28
-110.38
-92.74
-62.72
-67.51
-86.47
Other Direct Exp. Paid
0.00
0.00
0.00
-2.71
0.81
1.12
-0.09
0.77
0.31
0.17
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-710.56
-404.91
-1,151.88
-888.21
-759.07
-355.83
-732.52
-467.96
-441.46
-201.69
Net Fixed Assets
-621.08
-796.57
-582.72
-278.38
-570.07
-501.10
-523.07
-322.80
-267.98
-350.99
Net Investments
-184.99
163.48
-186.58
-164.16
-22.99
206.00
-131.91
-140.01
-134.32
139.49
Others
95.51
228.18
-382.58
-445.67
-166.01
-60.73
-77.54
-5.15
-39.16
9.81
Cash from Financing Activity
-214.51
-108.50
476.95
329.93
392.31
-63.48
372.99
135.40
46.74
226.79
Net Cash Inflow / Outflow
-20.12
23.55
-52.37
38.89
103.19
-45.92
83.23
54.49
-135.89
223.73
Opening Cash & Equivalents
306.33
282.78
335.15
339.90
274.15
320.06
236.84
182.35
314.01
87.94
Closing Cash & Equivalent
286.21
306.33
282.78
378.79
377.33
274.15
320.06
236.84
178.12
311.67

Financial Ratios

Consolidated /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Book Value (Rs.)
238.84
233.02
237.25
238.81
227.87
213.96
197.43
183.55
146.78
133.81
ROA
2.05%
0.65%
1.10%
3.01%
5.51%
6.00%
6.69%
5.56%
5.09%
4.43%
ROE
6.07%
1.81%
2.68%
6.41%
10.59%
10.66%
11.28%
9.82%
9.99%
8.35%
ROCE
10.24%
7.12%
6.94%
8.57%
12.09%
12.71%
13.79%
13.43%
12.51%
10.96%
Fixed Asset Turnover
1.52
1.43
1.44
1.40
1.32
1.32
1.31
1.34
1.37
1.29
Receivable days
35.07
34.88
34.21
35.79
39.79
41.34
41.65
39.84
36.65
35.78
Inventory Days
21.83
22.86
21.96
22.21
22.16
20.70
19.86
20.29
20.99
23.18
Payable days
32.37
31.05
33.50
36.33
29.38
27.43
26.31
29.25
35.67
33.61
Cash Conversion Cycle
24.54
26.70
22.66
21.67
32.58
34.61
35.20
30.88
21.97
25.34
Total Debt/Equity
1.10
1.06
0.95
0.85
0.63
0.45
0.44
0.33
0.52
0.55
Interest Cover
2.14
1.58
1.70
2.69
4.86
4.41
4.87
4.66
4.36
4.28

News Update


  • Apollo Hospitals launches ‘Apollo Life Saver’
    7th Oct 2019, 10:14 AM

    Apollo Life Saver will educate the public and create awareness about medical emergency services

    Read More
  • Apollo Hospitals gets shareholders' nod to raise up to Rs 500 crore via NCDs
    30th Sep 2019, 10:21 AM

    The proposal was approved by the requisite majority in the annual general meeting held on September 27, 2019

    Read More
  • Apollo Hospitals gets CCI’s nod for restructuring of pharmacy business
    24th Sep 2019, 10:47 AM

    Following the transaction, Apollo Pharmacy will be a wholly-owned subsidiary of Apollo Medicals

    Read More
  • Apollo Hospitals ties up with Zipline: Report
    20th Sep 2019, 10:54 AM

    The Hospital will explore and leverage drone technology to deliver emergency aids and organs

    Read More
  • Apollo Hospitals, EESL partner to install public EV charging stations in its hospitals
    19th Aug 2019, 10:16 AM

    This is a first such MoU by EESL with a private partner, to set up public charging infrastructure in the country

    Read More
  • Apollo Hospitals Enterprise reports 2-fold jump in Q1 consolidated net profit
    14th Aug 2019, 11:21 AM

    Total consolidated income of the company increased by 16.55% at Rs 2,581.75 crore for Q1FY20

    Read More
  • Apollo Hospital Ent. - Quarterly Results
    13th Aug 2019, 16:50 PM

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.